文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

遗传性非球形细胞溶血性贫血所致铁过载导致的肝硬化

Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.

作者信息

Hilgard Philip, Gerken Guido

机构信息

Universitatsklinikum Essen, Klinik fur Gastroenterologie and Hepatologie, Hufelandstrabe 55, 45122 Essen, Germany.

出版信息

World J Gastroenterol. 2005 Feb 28;11(8):1241-4. doi: 10.3748/wjg.v11.i8.1241.


DOI:10.3748/wjg.v11.i8.1241
PMID:15754414
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4250723/
Abstract

Nonspherocytic hereditary anemias are occasionally accompanied by significant iron overload but the significance for the development of chronic liver disease is not clear. We described two cases of patients with chronic liver disease and severe iron overload due to chronic hereditary hemolysis. Both patients have had signs of liver cirrhosis and severe hemolysis since childhood. A hereditary pyruvate kinase deficiency (PKD) was discovered as the underlying reason for the hemolysis. Sequencing of the pyruvate kinase gene showed a mutation within exon 11. Liver histology in both patients revealed cirrhosis and a severe iron overload but primary hemochromatosis was excluded by HFE-gene analysis. An iron reduction therapy with desferrioxamine led to significant decrease of serum ferritin and sustained clinical improvement. PKD-induced hemolysis may cause severe iron overload even in the absence of HFE-genotype abnormalities. This secondary iron overload can lead to chronic liver disease and cirrhosis. Therefore, the iron metabolism of PKD patients has to be closely monitored and iron overload should be consequently treated.

摘要

非球形细胞性遗传性贫血偶尔会伴有显著的铁过载,但对慢性肝病发展的意义尚不清楚。我们描述了两例因慢性遗传性溶血导致慢性肝病和严重铁过载的患者。两名患者自童年起就有肝硬化和严重溶血的迹象。发现遗传性丙酮酸激酶缺乏症(PKD)是溶血的根本原因。丙酮酸激酶基因测序显示第11外显子内有一个突变。两名患者的肝脏组织学检查均显示肝硬化和严重铁过载,但通过HFE基因分析排除了原发性血色素沉着症。去铁胺铁还原疗法导致血清铁蛋白显著降低,并持续改善临床症状。即使在没有HFE基因型异常的情况下,PKD诱导的溶血也可能导致严重的铁过载。这种继发性铁过载可导致慢性肝病和肝硬化。因此,必须密切监测PKD患者的铁代谢,并相应地治疗铁过载。

相似文献

[1]
Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.

World J Gastroenterol. 2005-2-28

[2]
Successful Liver Transplantation for Adolescent Patient With Pyruvate Kinase Deficiency-induced Cirrhosis.

J Pediatr Hematol Oncol. 2021-5-1

[3]
How we manage patients with pyruvate kinase deficiency.

Br J Haematol. 2019-1-25

[4]
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.

Blood Adv. 2024-5-28

[5]
Unexpectedly high but still asymptomatic iron overload in a patient with pyruvate kinase deficiency.

Hematol J. 2004

[6]
Successful Liver Transplants for Liver Failure Associated With Pyruvate Kinase Deficiency.

Pediatrics. 2018-4

[7]
Management of pyruvate kinase deficiency in children and adults.

Blood. 2020-9-10

[8]
Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases.

Blood Cells Mol Dis. 2001

[9]
An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency.

Expert Rev Hematol. 2022-10

[10]
Identification and in silico characterization of a novel PKLR genotype in a Turkish newborn.

Mol Biol Rep. 2020-10

引用本文的文献

[1]
Acute-on-Chronic Liver Failure and Successful Liver Transplantation in Pyruvate Kinase Deficiency.

ACG Case Rep J. 2023-9-5

[2]
Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency.

Qual Life Res. 2018-11-19

[3]
Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.

Mol Ther. 2016-8

[4]
Prominent basophilic stippling and hemochromatosis in glucose-6-phosphate dehydrogenase deficiency.

Int J Hematol. 2015-2

[5]
Bilirubin cholelithiasis and haemosiderosis in an anaemic pyruvate kinase-deficient Somali cat.

J Small Anim Pract. 2008-9

[6]
Clinical course of pyruvate kinase deficiency in Abyssinian and Somali cats.

J Feline Med Surg. 2008-4

本文引用的文献

[1]
Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.

Biol Blood Marrow Transplant. 2003-11

[2]
Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias.

Blood. 2003-1-1

[3]
Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases.

Blood Cells Mol Dis. 2001

[4]
Pathogenesis of liver fibrosis: role of oxidative stress.

Mol Aspects Med. 2000-6

[5]
Six previously undescribed pyruvate kinase mutations causing enzyme deficiency.

Blood. 1998-7-15

[6]
Molecular analysis of 29 pyruvate kinase-deficient patients from central Europe with hereditary hemolytic anemia.

Blood. 1997-3-1

[7]
Molecular basis of erythroenzymopathies associated with hereditary hemolytic anemia: tabulation of mutant enzymes.

Am J Hematol. 1996-2

[8]
Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: implications for gene therapy of human PK deficiency.

Blood. 1994-4-15

[9]
Hemolytic anemias.

Rev Invest Clin. 1994-4

[10]
Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients.

Br J Haematol. 1995-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索